Bigul

VENUS REMEDIES LTD. - 526953 - Statement Of Investor Complaints For The Quarter Ended December 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 027270 Name of the Signatory :- NehaDesignation :- Company Secretary and Compliance Officer
09-01-2020
Bigul

VENUS REMEDIES LTD. - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants)Regulation, 2018, we enclose herewith Confirmation Certificate received from our Registrar & Transfer Agent, M/s. Link Intime India Pvt Ltd. for the quarter ended 31.12.2019.
08-01-2020
Bigul

VENUS REMEDIES LTD. - 526953 - Shareholding for the Period Ended December 31, 2019

Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here
07-01-2020
Bigul

VENUS REMEDIES LTD. - 526953 - Closure of Trading Window

Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform that the trading window for dealing in equity shares of the Company has been closed for all Designated Persons of the Company, as defined under the said Regulations, from January 1, 2020 till 48 hours from the declaration of the Unaudited Financial Results for the Quarter ending December 31, 2019.
06-01-2020
Bigul

Venus Remedies Ltd - 526953 - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of The SEBI (LODR) Regulations, 2015 As On 30Th September, 2019

Pursuant to regulation 23(9) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015, kindly find enclosed herewith a disclosure on related party transaction on Consolidated basis for the half year ended on 30th September 2019.
07-12-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Standalone & Consolidated Unaudited Financial Results For The Quarter Ended On 30.09.2019.

Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30.09.2019.
12-11-2019
Bigul

Venus Remedies Ltd - 526953 - Outcome of Board Meeting

This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30.09.2019. Meeting concluded at 7:30 pm.
12-11-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication for Notice of Board meeting to be held on 12.11.2019.
02-11-2019
Next Page
Close

Let's Open Free Demat Account